Melanocortin-3 Receptor Regulates the Normal Fasting Response
Overview
Authors
Affiliations
The melanocortin-3 receptor-deficient (MC3-R(-/-)) mouse exhibits mild obesity without hyperphagia or hypometabolism. MC3-R deletion is reported to increase adiposity, reduce lean mass and white adipose tissue inflammation, and increase sensitivity to salt-induced hypertension. We show here that the MC3-R(-/-) mouse exhibits defective fasting-induced white adipose tissue lipolysis, fasting-induced liver triglyceride accumulation, fasting-induced refeeding, and fasting-induced regulation of the adipostatic and hypothalamic-adrenal-pituitary axes. Close examination of the hypothalamic-pituitary-adrenal axis showed that MC3-R(-/-) mice exhibit elevated nadir corticosterone as well as a blunted fasting-induced activation of the axis. The previously described phenotypes of this animal and the reduced bone density reported here parallel those of Cushing syndrome. Thus, MC3-R is required for communicating nutritional status to both central and peripheral tissues involved in nutrient partitioning, and this defect explains much of the metabolic phenotype in the model.
Pro-Opiomelanocortin and Melanocortin Receptor 3 and 4 Mutations in Genetic Obesity.
Yanik T, Durhan S Biomolecules. 2025; 15(2).
PMID: 40001512 PMC: 11853658. DOI: 10.3390/biom15020209.
Melanocortin 3 receptor regulates hepatic autophagy and systemic adiposity.
Patel T, Jun J, Seo A, Levi N, Elizondo D, Chen J Nat Commun. 2025; 16(1):1690.
PMID: 39956805 PMC: 11830824. DOI: 10.1038/s41467-025-56936-1.
Medial hypothalamic MC3R signalling regulates energy rheostasis in adult mice.
Possa-Paranhos I, Butts J, Pyszka E, Nelson C, Congdon S, Cho D J Physiol. 2024; 603(2):379-410.
PMID: 39718394 PMC: 11737543. DOI: 10.1113/JP286699.
Fasting-induced activity changes in MC3R neurons of the paraventricular nucleus of the thalamus.
Chesters R, Zhu J, Coull B, Baidoe-Ansah D, Baumer L, Palm L Life Sci Alliance. 2024; 7(10).
PMID: 39107065 PMC: 11303869. DOI: 10.26508/lsa.202402754.
Dahir N, Gui Y, Wu Y, Sweeney P, Rouault A, Williams S J Clin Invest. 2024; 134(14).
PMID: 39007271 PMC: 11245150. DOI: 10.1172/JCI178250.